Adrenocortical carcinoma (ACC) is a rare endocrine malignancy arising from the adrenal
cortex often with unexpected biological behavior. It can occur at any age, with two peaks of …

Simple Summary Pediatric adrenocortical tumors are rare. Little information is available on
the incidence, risk factors, prognostic factors, treatment, and overall survival. In this …

Simple Summary Adrenocortical carcinoma (ACC) is a rare and malignant disease with a
poor prognosis in advanced disease. The complexity of ACC management requires a …

Background Numerous studies have suggested that ferroptosis plays an important
regulatory role in cancer cell death. Nonetheless, the potential effects of ferroptosis …

Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy. For stage I and II
tumors, surgery is a curative option, but even in these cases recurrence is frequent. Practical …

Abstract Background Randomised controlled trials (RCTs) are considered the “gold
standard” for evaluating the effectiveness of interventions in clinical research. However …

Background and purpose Pediatric adrenocortical carcinoma (pACC) is a rare disease with
poor prognosis. Publications on radiotherapy (RT) are scarce. This review summarizes the …

Surgery is central to the cure of most solid cancers and an integral part of modern
multimodal cancer management for early and advanced stage cancers. Decisions made by …

As the Japan Endocrine Society (JES) celebrates its 100th anniversary, I have had the
opportunity to look back on my past 50 years of involvement with endocri‐nology practice …

Objective To assess the impact of postoperative radiotherapy on the outcomes of resected
adrenocortical carcinoma in a real-world setting. Methods The Surveillance, Epidemiology …